Joint-Ritis extensions
This article was originally published in The Tan Sheet
Executive Summary
Naturopathic Labs promotes two new Joint-Ritis vanishing cream formulas, including non-greasy vanishing cream (16% menthol) and vanishing cream non-greasy odor-free (10% trolamine salicylate), with $3-off coupon in Sept. 8 FSI. New topical joint health products, which launched this summer, will complement original two Joint-Ritis ointments. Firm began extensive print, radio ad campaign last November (1"The Tan Sheet" Nov. 26, 2001, p. 8). Naturopathic continues to highlight presence of glucosamine and chondroitin as "triple skin conditioners" on front panel, even though National Advertising Division has recommended firm move reference elsewhere on Joint-Ritis' labeling. FTC is reviewing the NAD decision (2"The Tan Sheet" July 15, 2002, p. 5)...
You may also be interested in...
Joint-Ritis Labeling Potentially Misleading; NARB Agrees With NAD Review
Naturopathic Labs' assertion that FTC's consent decree approving the packaging of SmartScience's JointFlex cream also applies, by extension, to the labeling for Naturopathic's Joint-Ritis product has drawn dis-agreement from the National Advertising Division
Joint-Ritis Ranks Second Among External Analgesic Rubs – IRI Data
Naturopathic Labs has extended its Joint-Ritis advertising campaign from exclusively radio spots to include a print component
Sumitomo To Reprioritize Pipeline After Ulotaront’s Phase III Fail
Sumitomo Pharma is to focus more on late-stage candidates in oncology and cell/gene therapy while passing on full global rights for ulotaront and SEP-380135 to Otsuka.